Condition

Chemotherapy-induced Peripheral Neuropathy

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 25 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials25
Recruiting1
Common interventions25
Lead sponsors shown15
Advertisement

Clinical trials

25 shown
Transcutaneous Electrical Acupoint Stimulation on Symptoms Associated with Chemotherapy Induced Peripheral NeuropathyNCT05904340 · 2023-07-01
RECRUITING
Neurocognitive and Psychological Impact of Chemotherapy in Breast Cancer Patients: A Prospective Observational StudyNCT07184749 · 2025-10-01
NOT_YET_RECRUITING
Evaluation of Hydroxychloroquine to Prevent CIPNNCT05689359 · 2024-06-01
WITHDRAWN
Paclitaxel-induced Polyneuropathy in Breast Cancer: Early Detection, Risk Factors, Quality of Life and Lifestyle OutcomesNCT06052345 · 2024-03-31
WITHDRAWN
Symptoms Associated with Chemotherapy-Induced Peripheral NeuropathyNCT06352567 · 2024-01-18
COMPLETED
The Mamma HiToP StudyNCT06132776 · 2023-11-03
UNKNOWN
Role of Curcumin in Paclitaxel Induced PNNCT05966441 · 2023-08-30
UNKNOWN
The AIUR Trial: Surgical Gloves to Prevent Peripheral NeuropathyNCT05771974 · 2023-06-13
ACTIVE_NOT_RECRUITING
The Effect of Cryotherapy on Breast Cancer PatientsNCT06020222 · 2023-05-01
UNKNOWN
Preventing Chemotherapy-Induced Peripheral Neuropathy With Acupuncture (PACT Trial)NCT05528263 · 2022-09-08
COMPLETED
CIPN in Early Stage Breast Cancer PatientsNCT05441722 · 2022-05-26
UNKNOWN
Risk Prediction of Taxane Chemotherapy-Induced Peripheral NeuropathyNCT04932031 · 2022-05-25
TERMINATED
Chemotherapy-induced Peripheral Neuropathy (CIPN) on Motor and Sensory FunctionNCT04799080 · 2021-03-06
COMPLETED
Lidocaine Versus Duloxetine for the Prevention of Taxane-Induced Peripheral Neuropathy In Breast Cancer PatientsNCT04732455 · 2021-01-15
COMPLETED
Home-Based Physical Activity Intervention for Taxane-Induced CIPNNCT04621721 · 2020-08-14
UNKNOWN
Effect of Hemp-CBD on Patients With CIPNNCT04398446 · 2020-05-27
UNKNOWN
Cryotherapy vs. Cryocompression for Preventing Chemotherapy-induced-peripheral-neuropathy in Women Undergoing ChemotherapyNCT04632797 · 2020-02-03
UNKNOWN
NR in Chemo-induced Peripheral NeuropathyNCT03642990 · 2019-11-08
TERMINATED
Acupuncture Treatment of Chemotherapy-Induced Peripheral Neuropathy in WomenNCT04067544 · 2019-11-05
TERMINATED
CIPN-prevention Trial Evaluating the Efficacy of Hand-cooling and Hand-compressionNCT06541769 · 2019-10-15
COMPLETED
Pain, Psychological, and Endocannabinoid Responses to Yoga in Breast Cancer Survivors With Chemotherapy-induced Neuropathic PainNCT04075097 · 2019-07-31
COMPLETED
Involvement of SK3 Calcium Channel in Taxane NeuropathyNCT03816904 · 2019-02-06
COMPLETED
Acupuncture on Chemotherapy-induced Peripheral NeuropathyNCT03626220 · 2018-06-27
COMPLETED
Chemotherapy Induced Peripheral Neuropathy (CIPN)NCT03272919 · 2017-09-28
COMPLETED
Chemotherapy-Induced Peripheral Neuropathy SurveyNCT01016028 · 2009-11-01
WITHDRAWN

Common interventions

Trial status mix

COMPLETED9
UNKNOWN7
TERMINATED3
WITHDRAWN3
ACTIVE_NOT_RECRUITING1
NOT_YET_RECRUITING1
RECRUITING1

Phase mix

NA14
PHASE24
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.